E5103 Non-Protocol Therapy Form [Form No. 2814v2] NCT00433511 Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer Source Form: NCI FormBuilder:

  1. 8/26/12 8/26/12 -
  2. 1/9/15 1/9/15 - Martin Dugas
  3. 6/18/15 6/18/15 -
Uploaded on:

June 18, 2015

To request one please log in.
License :
Creative Commons BY-NC 3.0 Legacy
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

E5103 Non-Protocol Therapy Form NCT00433511

Instructions: Use this form to capture the FIRST occurrence of non-protocol anti-tumor therapy per registration step ONLY if patient's disease is still stable or in partial or complete remission and has not progressed/relapsed from protocol therapy.

ECOG clinical trial administrative data
Reporting Period
Patient demographics
Data amendment
Non-Protocol Therapy
Non-Protocol Chemotherapy
Non-Protocol Hormonal Therapy?
Non-Protocol Immunotherapy? (/Biological Response Modifiers)
Non-protocol high dose chemotherapy/stem cell transplant (Autologous or Allogeneic)
Non-Protocol Surgery
Non-Protocol Radiation Therapy?
Other Non-Protocol Therapy
Was the non-protocol therapy given for the disease of this protocol (NOTE: Treatment for a second primary in the same organ site would not be considered therapy for disease of this protocol. - NOTE: Submit ECOG Second Primary Form if applicable.)

Similar models

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial